Nebivolol (versus unexposed) updated on 12-17-2024

Table   Graphic     exposition period:

Congenital malformations
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
All congenital malformations (majors, minors, majors and minors, or unspecified)1.42 [0.19, 10.47]-1 study4,05529not evaluable ROB-
Major congenital malformations1.42 [0.19, 10.47]-1 study4,05529not evaluable ROB-

Hide endpoints reported in only one study ...